Table 2.
In-hospital treatment and events in 1062 patients with acute coronary syndrome
| NGT | IFG/IGT | DiabetesA | DiabetesB | P | ||||
|---|---|---|---|---|---|---|---|---|
| No. | 295 | 299 | 156 | 312 | ||||
| Female/male (n) | 76/219 | 77/222 | 40/116 | 88/224 | NS | |||
| Coronary angiography % | 92.5 (273)l | 94.0 (281)l | 92.3 (144)l | 73.7 (230)c,f,i | <0.001 | |||
| Coronary angio-graphy in 928 patients | ||||||||
| PCI % (of 928) | 70.7 (193)l | 66.5 (187)l | 69.4 (100)l | 57.4 (132)c,f,i | <0.05 | |||
| PCI in 612 patients | ||||||||
| Stent % (of 612) | 87.0 (168) | 87.7 (164) | 87.0 (87) | 89.4 (118) | NS | |||
| Stent in 537 patients | ||||||||
| BMS % | 81.5 (137)l | 82.9 l (136) | 81.6 (71)l | 60.2 (71)c,f,i | <0.001 | |||
| DES % | 18.5 (31)l | 17.1l (28) | 18.4 (16)l | 39.8 (47)c,f,i | <0.001 | |||
| CABG % | 13.9 (41) | 16.7 (50) | 16.7 (26) | 17.9 (56) | NS | |||
| LVEF evaluation % | 83.4 (246)l | 83.3 (249)l | 87.2 (136)l | 76.0 (237)c,f,i | <0.001 | |||
| Normal LVEF (>50 %) | 74.4 (183)l | 72.3 (180)l | 67.6 (92)l | 50.6 (120)c,f,i | <0.001 | |||
| Reduced LVEF (<50 %) | 25.6 (63)l | 27.7 (69)l | 32.4 (44)l | 49.4 (117)c,f,i | <0.001 | |||
Parenthesis show number of individuals
PCI percutaneous coronary intervention, BMS bare metal stents, DES drug-eluting stents, CABG coronary artery bypass graft, LVEF left ventricular ejection fraction
vs NGT, ap < 0.05, b p < 0.01, c p < 0.001; vs IFG/IGT, d p < 0.05, e p < 0.01, f p < 0.001; vs Diabetes OGTT, g p < 0.05, h p < 0.01, i p < 0.001; vs known diabetes, j p < 0.05, k p < 0.01, l p < 0.001
APatients with diabetes discovered by OGTT
BPatients with known diabetes at admission